We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
-7.13%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$131M
Cap. Flow
-$83.5M
Cap. Flow %
-38.69%
Top 10 Hldgs %
42.5%
Holding
85
New
16
Increased
22
Reduced
28
Closed
19

Top Buys

Rank Stock Value
1
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$4.88M
2
SAGE
Sage Therapeutics
SAGE
+$4.34M
3
TECX
Tectonic Therapeutic
TECX
+$4.04M
4
SDGR icon
Schrodinger
SDGR
+$3.02M
5
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
+$2.98M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$14.2M
2
BSX icon
Boston Scientific
BSX
+$12.4M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$9.42M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$8.04M
5
TFX icon
Teleflex
TFX
+$7M

Sector Composition

Rank Sector Weight
1 Healthcare 92.89%
2 Technology 1.17%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$318B
$16.6M 7.7%
226,186
-4,374
-2% -$344K
NBIX icon
2
Neurocrine Biosciences
NBIX
$16.6B
$11.1M 5.16%
128,526
-26,899
-17% -$2.63M
GWPH
3
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.8M 4.98%
122,778
+27,778
+29% +$2.94M
VRTX icon
4
Vertex Pharmaceuticals
VRTX
$126B
$10.2M 4.72%
42,842
-2,334
-5% -$535K
UNH icon
5
UnitedHealth
UNH
$370B
$8.73M 4.04%
35,000
+10,000
+40% +$2.75M
DXCM icon
6
DexCom
DXCM
$32B
$8.63M 4%
128,132
-11,868
-8% -$739K
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.31M 3.39%
246,906
-18,934
-7% -$641K
XENE icon
8
Xenon Pharmaceuticals
XENE
$6.12B
$6.69M 3.1%
590,267
+2,208
+0.4% +$31.4K
AXNX
9
DELISTED
Axonics, Inc. Common Stock
AXNX
$6.15M 2.85%
241,909
+75,678
+46% +$2.25M
DRNA
10
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5.53M 2.56%
300,805
+60,805
+25% +$1.18M
ICAD
11
DELISTED
iCAD Inc
ICAD
$5.33M 2.47%
725,590
+124,904
+21% +$1.22M
MNTA
12
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$4.77M 2.21%
+175,453
New +$4.88M
TECX
13
Tectonic Therapeutic
TECX
$606M
$4.6M 2.13%
24,633
+17,133
+228% +$4.04M
MTEM
14
DELISTED
Molecular Templates, Inc.
MTEM
$4.56M 2.11%
22,858
+78
+0.3% +$17.1K
ISRG icon
15
Intuitive Surgical
ISRG
$134B
$4.49M 2.08%
27,210
-19,290
-41% -$3.53M
KRMD icon
16
KORU Medical Systems
KRMD
$164M
$4.29M 1.99%
571,985
+43,413
+8% +$292K
SILK
17
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$4.25M 1.97%
135,000
-60,000
-31% -$2.4M
KPTI icon
18
Karyopharm Therapeutics
KPTI
$48M
$4.15M 1.92%
14,387
-18,946
-57% -$5.23M
SGEN
19
DELISTED
Seagen Inc. Common Stock
SGEN
$4.05M 1.88%
35,110
-85,111
-71% -$9.42M
EIDX
20
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$3.97M 1.84%
81,085
-126,186
-61% -$6.43M
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$29.3B
$3.96M 1.83%
36,363
+1,363
+4% +$157K
TPTX
22
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$3.59M 1.66%
80,318
-21,116
-21% -$1.12M
SDGR icon
23
Schrodinger
SDGR
$1.36B
$3.45M 1.6%
+80,071
New +$3.02M
XLRN
24
DELISTED
Acceleron Pharma
XLRN
$3.37M 1.56%
+37,500
New +$2.91M
IQV icon
25
IQVIA
IQV
$39.3B
$3.24M 1.5%
30,000
-11,250
-27% -$1.61M
1
2 3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Parkman Healthcare Partners held 85 positions worth $216M, down 38% from $346M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Parkman Healthcare Partners withdrew a net $83.5M in Q1 2020, closing 19 positions and reducing 28 holdings. Its most notable exit was Zimmer Biomet, an estimated $14.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Technology and Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Momenta Pharmaceuticals, Inc. worth $4.77M.

  • Parkman Healthcare Partners's largest Q1 2020 buy was Momenta Pharmaceuticals, Inc.: 175,453 shares worth $4.77M.
  • Parkman Healthcare Partners added most to Tectonic Therapeutic in Q1 2020, an estimated $4.04M increase.
  • Parkman Healthcare Partners's biggest Q1 2020 reduction was Seagen Inc. Common Stock, cutting an estimated $9.42M.
  • Parkman Healthcare Partners fully exited Zimmer Biomet in Q1 2020, selling an estimated $14.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 42% of its $216M portfolio in Q1 2020.
  • Parkman Healthcare Partners opened 16 new positions and closed 19 in Q1 2020.
  • Parkman Healthcare Partners's portfolio value fell 38% quarter-over-quarter to $216M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2020, filed 15 May 2020.